What is NDC 16110-915?

16110-915 is the product NDC for Tazorac (tazarotene), Tazarotene .05 mg/g cream, listed with the FDA by Almirall, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Almirall, LLC, NDC labeler code 16110. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tazorac?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tazorac NDC 16110-915 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)16110-915Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16110-0915Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16110-915-30	1611009153016110091530	1 TUBE in 1 CARTON (16110-915-30) / 30 g in 1 TUBEMarketed from Feb 3, 2020
16110-915-60	1611009156016110091560	1 TUBE in 1 CARTON (16110-915-60) / 60 g in 1 TUBEMarketed from Feb 3, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tazorac
Generic name (nonproprietary): tazarotene
Active ingredients: Tazarotene — .05 mg/g
Dosage form: Cream
Route: Cutaneous
Labeler: Almirall, LLCNDC labeler code 16110
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021184
Marketing start: Feb 3, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 16110-915_ee97b76e-eb11-4165-ae85-1277eba9ff35SPL ID ee97b76e-eb11-4165-ae85-1277eba9ff35SPL set ID 021744d1-a6d7-4ad6-99c2-7187c24e64c6UNII 81BDR9Y8PSUPC 0316110915609, 0316110916606, 0316110915302, 0316110916309
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N416110091530 followed by a unit qualifier and the quantity

Package 16110-0915-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 13, 2025.

Indications (excerpt from the label)

TAZORAC ® Cream 0.05% and 0.1% is a retinoid indicated for the topical treatment of plaque psoriasis. ( 1.1 ) TAZORAC Cream 0.1% is indicated for the topical treatment of acne vulgaris. ( 1.2 ) 1.1 Plaque Psoriasis TAZORAC ® (tazarotene) Cream, 0.05% and 0.1% are indicated for the topical treatment of patients with plaque psoriasis. 1.2 Acne Vulgaris TAZORAC (tazarotene) Cream, 0.1% is also indicated for the topical treatment of patients with acne vulgaris.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 16110-915

What is NDC 16110-915?: 16110-915 is the product NDC for Tazorac (tazarotene), Tazarotene .05 mg/g cream, listed with the FDA by Almirall, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tazorac (Tazarotene).
What is the active ingredient?: Tazarotene.
Who is the labeler?: Almirall, LLC, NDC labeler code 16110. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tazorac?: 3 other product NDCs are listed under this name. See all Tazorac NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tazorac NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tazoractazarotene	Tazarotene 1 mg/g	GelCutaneous	Almirall, LLC	16110-042	16110-0042-1016110-0042-30
Tazoractazarotene	Tazarotene .5 mg/g	GelCutaneous	Almirall, LLC	16110-833	16110-0833-1016110-0833-30
Tazoractazarotene	Tazarotene .1 mg/g	CreamCutaneous	Almirall, LLC	16110-916	16110-0916-3016110-0916-60

Other NDCs under NDA 021184

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021184
Product	Strength	Form · route	Labeler	Product NDC
Tazoractazarotene	Tazarotene .1 mg/g	CreamCutaneous	Almirall, LLC	16110-916

Tazorac (Tazarotene) NDC 16110-915

NDC codes

Product information

Billing references

Product label

About NDC 16110-915

Other NDCs under NDA 021184

Log in to keep searching

NDC codes

Product information

Billing references

Product label

About NDC 16110-915

Related NDCs: other Tazorac products

Other NDCs under NDA 021184